Catalogo dei prodotti della ricerca

Petrucci, Luigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.864
AS - Asia 1.249
EU - Europa 1.093
SA - Sud America 153
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.426
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.797
IT - Italia 620
SG - Singapore 463
CN - Cina 224
VN - Vietnam 188
HK - Hong Kong 131
BR - Brasile 112
IN - India 95
DE - Germania 87
SE - Svezia 72
FI - Finlandia 56
FR - Francia 49
CA - Canada 39
NL - Olanda 32
RU - Federazione Russa 30
GB - Regno Unito 29
JP - Giappone 26
BD - Bangladesh 23
TG - Togo 20
ZA - Sudafrica 20
AR - Argentina 19
PL - Polonia 19
BG - Bulgaria 18
ID - Indonesia 16
IE - Irlanda 16
UA - Ucraina 13
AT - Austria 11
ES - Italia 11
TR - Turchia 11
IQ - Iraq 10
MX - Messico 10
PK - Pakistan 10
EC - Ecuador 9
CO - Colombia 8
KR - Corea 7
BE - Belgio 6
KE - Kenya 6
MY - Malesia 6
PT - Portogallo 6
RO - Romania 6
UZ - Uzbekistan 6
SA - Arabia Saudita 5
EG - Egitto 4
MA - Marocco 4
PA - Panama 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
IR - Iran 3
PH - Filippine 3
TW - Taiwan 3
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GE - Georgia 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CU - Cuba 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
LI - Liechtenstein 1
MD - Moldavia 1
ML - Mali 1
NG - Nigeria 1
NP - Nepal 1
NR - Nauru 1
PE - Perù 1
PY - Paraguay 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 4.426
Salva come PNG Salva come JPEG
Città #
Singapore 258
Ashburn 205
Fairfield 161
Rome 149
San Jose 149
Hong Kong 121
Chandler 77
Ho Chi Minh City 67
Los Angeles 67
Seattle 67
Houston 65
Woodbridge 61
Dallas 55
Santa Clara 54
Cambridge 53
Wilmington 48
Hanoi 47
Milan 45
Ann Arbor 44
Beijing 44
New York 41
San Paolo di Civitate 36
Helsinki 34
Munich 29
Princeton 28
Lauterbourg 26
Buffalo 25
Frankfurt am Main 24
Council Bluffs 21
Hillsboro 21
Lawrence 21
Millbury 21
The Dalles 21
Lomé 20
Naples 19
Tokyo 19
Sofia 18
Johannesburg 16
Warsaw 16
Cosenza 15
Redondo Beach 15
Florence 14
Plano 14
San Diego 14
São Paulo 14
Boston 13
Dublin 13
Bari 12
Orem 12
Andover 11
Nuremberg 11
Haiphong 10
Atlanta 9
Bengaluru 9
Bologna 9
Chicago 9
Jakarta 9
Moscow 9
Bremen 8
Montreal 8
Turin 8
Turku 8
Vancouver 8
Brooklyn 7
Columbus 7
Elk Grove Village 7
Abrantes 6
Biên Hòa 6
Brussels 6
Cagliari 6
Denver 6
Lucca 6
Modena 6
Pune 6
Shanghai 6
Squamish 6
Stockholm 6
Tashkent 6
Toronto 6
Baghdad 5
Boardman 5
Da Nang 5
Des Moines 5
Falkenstein 5
Hefei 5
Kuala Lumpur 5
London 5
Norwalk 5
Parker 5
Poplar 5
Quito 5
San Mateo 5
Trento 5
Verona 5
Busto Arsizio 4
Casablanca 4
Eindhoven 4
Istanbul 4
Jinan 4
Lappeenranta 4
Totale 2.753
Salva come PNG Salva come JPEG
Nome #
Evoluzione del trattamento del linfoma primitivo del mediastino a cellule B 400
EFFICACY, SAFETY AND COST ANALYSIS OF SUBCUTANEOUS VS INTRAVENOUS RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RCHOP 212
Management of elderly and unfit patients with chronic lymphocytic leukemia 187
5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials. 184
A prospective unicentric survey on donor-specific antibodies DSA and desensitization strategy 156
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma. a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 154
Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response 150
A prognostic model for patients with lymphoma and COVID-19. a multicentre cohort study 150
COVID-19 in patients with hematologic disorders undergoing therapy: perspective of a large referral hematology center in Rome 146
Human herpesvirus-8–positive primary effusion lymphoma in HIV-negative patients: single institution case series with a multidisciplinary characterization 143
Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib. 136
INTEGRATION OF CD200, CD43 AND ROR1 IN MULTIPARAMETER FLOW CYTOMETRY (MFC) ROUTINE PANELS FOR THE DIFFERENTIAL DIAGNOSIS OF B-CELL LYMPHOPROLIFERATIVE DISORDERS (B-LPDS) 134
Combination of azacitidine and ESA in myelodysplastic patients: The need for prospective studies 129
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Patients: A Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy 128
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy 127
Deferasirox treatment for myelodysplastic syndromes: "real-life" efficacy and safety in a single-institution patient population. 123
Lymphomatoid granulomatosis and large granular lymphocyte leukemia, a rare association of two lymphoproliferative disorders 120
Bing-Neel syndrome coexisting with oligodendroglioma 116
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 112
Omission of radiotherapy in primary mediastinal B-Cell lymphoma: IELSG37 trial results 110
Evaluation of prognostic factors for overall survival in patients with chronic myelomonocytic leukemia by different scoring systems: which is the best? 106
Low incidence rate of opportunistic and viral infections during imatinib treatment in chronic myeloid leukemia patients in early and late chronic phase. 105
MRI versus CT and PET/CT in the preoperative assessment of Hodgkin and non-Hodgkin lymphomas 105
PREDICTIVE FACTORS FOR INFECTIOUS ADVERSE EVENTS IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA TREATED WITH BENDAMUSTINE-RITUXIMAB (R)+/- R MAINTENANCE. RESULTS OF A RETROSPECTIVE ANALYSIS 100
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi 89
Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL) 85
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL) 84
Neutropenia at baseline could indicate poor prognosis in low/intermediate risk myelodysplastic syndrome patients 83
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study 82
Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis 77
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia 74
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study 73
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study 69
LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN COMPLETE MOLECULAR RESPONSE WITH ALPHA-INTERFERON AFTER TREATMENT DISCONTINUATION 63
Prognostic Features of Myelodysplastic Syndrome Patients Aged < 50 years: Update of a Single Institution Experience. 61
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels. 58
Lymphocyte recovery after bendamustine therapy in patients with mantle cell lymphoma. Results of a retrospective analysis and prognostic impact in the CAR-T era 55
null 51
Primary mediastinal large B-cell lymphoma: biological features, clinical characteristics and current treatment strategies 47
Totale 4.584
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.663
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 14 16
2021/2022318 5 9 26 27 34 20 3 35 24 30 43 62
2022/2023368 55 95 24 21 34 36 13 23 37 7 16 7
2023/2024226 14 21 18 13 20 53 15 21 6 24 13 8
2024/2025850 34 38 31 25 56 52 63 44 133 62 58 254
2025/20262.239 193 95 166 165 299 156 325 178 249 285 128 0
Totale 4.584